Scopia Capital Management LP Y M Abs Therapeutics, Inc. Transaction History

Scopia Capital Management LP

  • $485 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$19.51 - $28.31 $18 Million - $26.1 Million
-920,282 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$18.21 - $26.21 $12.2 Million - $17.5 Million
-667,284 Reduced 42.03%
920,282 $24.1 Million
Q3 2018

Nov 14, 2018
BUY
$24.0 - $26.97 $38.1 Million - $42.8 Million
1,587,566 New
1,587,566 $42.2 Million

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $487M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Scopia Capital Management LP Portfolio

Follow Scopia Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scopia Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Scopia Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email